✦ LIBER ✦

PDB45 COST-EFFECTIVENESS ANALYSIS OF SAXAGLIPTIN IN THE TREATMENT OF DIABETES MELLITUS TYPE 2 IN SPAIN

✍ Scribed by de Ramirez; A Arellano; M Brosa; J Franch; D Mauricio; C Alvarez; M Sanchez-Zamorano; B De Rivas

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PDB9 Cost-Effectiveness Analysis of Saxa

✍ E.E. Arinina; M. Rashyd 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 59 KB

PDB53 Cost-Effectiveness of Saxagliptin

✍ A. Juarez-Garcia; D. Casalvolone; L. Qatami; K. Bergenheim; B.M.K. Donato 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 57 KB

PDB37 THE COST-EFFECTIVENESS OF SAXAGLIP

✍ K Kolasa; M Niewada; J Puelles Fernandez de Troconiz; R Townsend; P McEwan 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 77 KB

PDB44 THE COST-EFFECTIVENESS OF SAXAGLIP

✍ W Erhardt; K Bergenheim; R Townsend; J Puelles Fernandez de Troconiz; P McEwan 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 97 KB

PDB35 THE COST OF DIABETES MELLITUS IN S

✍ C Rubio-Terrés; E Faure; F Poyato; A Del Castillo; P González 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 63 KB

Cost-effectiveness of saxagliptin (Ongly

✍ Granström, Ola; Bergenheim, Klas; McEwan, Phil; Sennfält, Karin; Henriksson, Mar 📂 Article 📅 2012 🏛 Elsevier 🌐 English ⚖ 602 KB